Drug Shortage Report for LORAZEPAM SUBLINGUAL
Report ID | 183599 |
Drug Identification Number | 02410745 |
Brand name | LORAZEPAM SUBLINGUAL |
Common or Proper name | Lorazepam Sublingual |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | LORAZEPAM |
Strength(s) | 0.5MG |
Dosage form(s) | TABLET |
Route of administration | SUBLINGUAL SUBLINGUAL |
Packaging size | 100BTL |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-02-28 |
Actual start date | |
Estimated end date | 2023-04-20 |
Actual end date | 2023-04-14 |
Shortage status | Resolved |
Updated date | 2023-04-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2023-04-17 | French | Compare |
v12 | 2023-04-17 | English | Compare |
v11 | 2023-03-30 | French | Compare |
v10 | 2023-03-30 | English | Compare |
v9 | 2023-03-16 | French | Compare |
v8 | 2023-03-16 | English | Compare |
v7 | 2023-03-08 | French | Compare |
v6 | 2023-03-08 | English | Compare |
v5 | 2023-03-01 | English | Compare |
v4 | 2023-02-14 | French | Compare |
v3 | 2023-02-14 | English | Compare |
v2 | 2023-02-03 | French | Compare |
v1 | 2023-02-03 | English | Compare |
Showing 1 to 13 of 13